Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Eliana Bignotti"'
Autor:
Maartje M. W. Luijten, Willem Jan van Weelden, Roy I. Lalisang, Johan Bulten, Kristina Lindemann, Heleen J. van Beekhuizen, Hans Trum, Dorry Boll, Henrica M. J. Werner, Luc R. C. W. van Lonkhuijzen, Refika Yigit, Camilla Krakstad, Petronella O. Witteveen, Khadra Galaal, Alexandra A. van Ginkel, Eliana Bignotti, Vit Weinberger, Sanne Sweegers, Ane Gerda Z. Eriksson, Diederick M. Keizer, Anja van de Stolpe, Andrea Romano, Johanna M. A. Pijnenborg, European Network for Individualized Treatment in Endometrial Cancer
Publikováno v:
Cancers, Vol 16, Iss 11, p 2084 (2024)
Background: Response to hormonal therapy in advanced and recurrent endometrial cancer (EC) can be predicted by oestrogen and progesterone receptor immunohistochemical (ER/PR-IHC) expression, with response rates of 60% in PR-IHC > 50% cases. ER/PR-IHC
Externí odkaz:
https://doaj.org/article/3d7b35ff64844380a4515ee7a33416cc
Autor:
Luca Forlani, Loris De Cecco, Vittorio Simeon, Biagio Paolini, Marina Bagnoli, Sabrina Chiara Cecere, Anna Spina, Eleonora Citeroni, Eliana Bignotti, Domenica Lorusso, Laura Arenare, Daniela Russo, Carmine De Angelis, Laura Ardighieri, Giosuè Scognamiglio, Michele Del Sesto, Germana Tognon, Daniela Califano, Clorinda Schettino, Paolo Chiodini, Francesco Perrone, Delia Mezzanzanica, Sandro Pignata, Antonella Tomassetti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-17 (2023)
Abstract Background Validated prognostic biomarkers for anti-angiogenic therapy using the anti-VEGF antibody Bevacizumab in ovarian cancer (OC) patients are still an unmet clinical need. The EGFR can contribute to cancer-associated biological mechani
Externí odkaz:
https://doaj.org/article/218fe5829cc64926a70c90f947c39308
Autor:
Chiara Romani, Luigi Lorini, Anna Bozzola, Eliana Bignotti, Michele Tomasoni, Laura Ardighieri, Mattia Bugatti, Simonetta Battocchio, Antonella Ravaggi, Davide Tomasini, Marco Ravanelli, Cristina Gurizzan, Davide Lombardi, Davide Mattavelli, Stefano Calza, Cesare Piazza, Paolo Bossi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Adenoid cystic carcinoma (ACC) of salivary gland is a slowly growing tumor showing a propensity for delayed recurrence, with decreased survival rates. The identification of poor prognosis patients may help in defining molecular-based targete
Externí odkaz:
https://doaj.org/article/5264e55f9dfa4d33b3204b77d6950bb3
Autor:
Cristina Gurizzan, Luigi Lorini, Alberto Paderno, Michele Tomasoni, Gabriele Zigliani, Anna Bozzola, Laura Ardighieri, Simonetta Battocchio, Eliana Bignotti, Antonella Ravaggi, Chiara Romani, Loris De Cecco, Mara Serena Serafini, Rosalba Miceli, Elena Bardellini, Alessandra Majorana, Cesare Piazza, Paolo Bossi
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Oral Potentially Malignant Disorders (OPMD) have a non-negligible malignant transformation rate of up to 8%. Loss of heterozygosity (LOH) in critical chromosomal loci has proven to be the most effective marker in defining the risk
Externí odkaz:
https://doaj.org/article/994233a8f3da46a6968df2983eeba321
Autor:
Antonella Ravaggi, Angela Gambino, Federico Ferrari, Alessandro Olivari, Laura Zanotti, Chiara Romani, Laura Ardighieri, Paolo Antonelli, Giorgia Garganese, Daniela Gallo, Giovanni Scambia, Eliana Bignotti, Enrico Sartori, Stefano Calza, Franco Odicino
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundRadical surgical resection of the primary tumor with mono/bilateral inguinofemoral lymph node dissection is the standard treatment for invasive vulvar squamous cell carcinoma (VSCC) and is frequently related to severe morbidity. Tailoring s
Externí odkaz:
https://doaj.org/article/3941391271cd493cbf7e45d02926ad73
Autor:
Antonella Ravaggi, Davide Capoferri, Laura Ardighieri, Iacopo Ghini, Federico Ferrari, Chiara Romani, Mattia Bugatti, Laura Zanotti, Stephanie Vrede, Germana Tognon, Johanna M. A. Pijnenborg, Enrico Sartori, Stefano Calza, Eliana Bignotti, Franco Odicino
Publikováno v:
Cancers, Vol 14, Iss 21, p 5429 (2022)
Histopathologic assessment of high-risk endometrial cancer (EC) suffers from intersubject variability and poor reproducibility. The pragmatic classification in four molecular subgroups helps to overcome these limits, showing a significant prognostic
Externí odkaz:
https://doaj.org/article/07e96ab8557a49dc9ba33081a3b145a6
Autor:
Laura Ardighieri, Francesco Missale, Mattia Bugatti, Luisa Benerini Gatta, Irene Pezzali, Matilde Monti, Stefano Gottardi, Laura Zanotti, Eliana Bignotti, Antonella Ravaggi, Germana Tognon, Franco Odicino, Stefano Calza, Yoann Missolo-Koussou, Carola Hermine Ries, Julie Helft, William Vermi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Ovarian carcinomas (OCs) are poorly immunogenic and immune checkpoint inhibitors (ICIs) have offered a modest benefit. In this study, high CD3+ T-cells and CD163+ tumor-associated macrophages (TAMs) densities identify a subgroup of immune infiltrated
Externí odkaz:
https://doaj.org/article/058f139e0f254749a968eaf80edeecd5
Autor:
Eliana Bignotti, Laura Zanotti, Paola Todeschini, Valentina Zizioli, Chiara Romani, Davide Capoferri, Germana Tognon, Enrico Sartori, Stefano Calza, Franco Odicino, Antonella Ravaggi
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
In spite of the effective implementation of screening programs, uterine cervical carcinoma (UCC) remains one of the major causes of cancer death among women around the world. The aim of this study was to investigate the prognostic value of serum huma
Externí odkaz:
https://doaj.org/article/5130fb4b05f14aa4be9ad2d0f243407e
Autor:
Chiara Romani, Valentina Zizioli, Marco Silvestri, Laura Ardighieri, Mattia Bugatti, Michela Corsini, Paola Todeschini, Sergio Marchini, Maurizio D'Incalci, Laura Zanotti, Antonella Ravaggi, Fabio Facchetti, Angela Gambino, Franco Odicino, Enrico Sartori, Alessandro Davide Santin, Stefania Mitola, Eliana Bignotti, Stefano Calza
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
High-grade serous ovarian carcinoma (HGSOC) usually spreads directly into the peritoneal cavity following a transcoelomic dissemination route, although distant hematogenous metastasis exist and have been reported. However, no tumor markers can curren
Externí odkaz:
https://doaj.org/article/8a3b8f139a7a4efa94b6ab8f116c19a7
Autor:
Daniela Califano, Daniela Gallo, Gian Luca Rampioni Vinciguerra, Rossella De Cecio, Laura Arenare, Simona Signoriello, Daniela Russo, Gabriella Ferrandina, Francesca Citron, Nunzia Simona Losito, Piera Gargiulo, Vittorio Simeon, Giovanni Scambia, Sabrina Chiara Cecere, Marco Montella, Nicoletta Colombo, Germana Tognon, Eliana Bignotti, Gian Franco Zannoni, Vincenzo Canzonieri, Alessandra Ciucci, Anna Spina, Giosuè Scognamiglio, Michele Del Sesto, Clorinda Schettino, Maria Carmela Piccirillo, Francesco Perrone, Paolo Chiodini, Sandro Pignata, Gustavo Baldassarre
Publikováno v:
Cancers, Vol 13, Iss 20, p 5152 (2021)
Background. Epithelial ovarian cancer (EOC) is a rare, highly lethal disease. In a subset of high grade EOC patients, maintenance therapy with the antiangiogenic drug Bevacizumab (BEV) is a valuable option. To date, no validated predictive or prognos
Externí odkaz:
https://doaj.org/article/a247cff30305469eafdd5d9e3c60bf05